A Phase 1 Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Compared to the Commercial Tablet Formulation in Healthy Participants. A Phase 1, Open-Label, Randomized, Single-Dose, Crossover Study to Estimate the Relative Bioavailability of PF-07321332 Following Oral Administration of 4 Different Formulations Relative to the Commercial Tablet Formulation in Healthy Adult Participants Under Fasted Conditions.